Ane Cecilie Dæhli Munk is a Lecturer at the University of Oslo , affiliated with the Faculty of Medicine . Her research focuses on molecular biomarkers , HPV genotypes , and immune responses in cervical intraepithelial neoplasia (CIN) regression and cervical cancer progression. PhD in Pathology from the University of Bergen (2012), thesis: "Molecular biomarkers, human papillomavirus-genotypes and clinical factors in regression prediction of cervical intraepithelial neoplasia grades 2-3" Current position: Consultant at the Women's Clinic, Stavanger University Hospital Her work identifies predictive markers for spontaneous CIN regression, emphasizing condom use and HPV typing to reduce unnecessary surgeries. Publications span journals like International Journal of Molecular Sciences , PLOS ONE , and Cancers , with key contributions to biomarker development and immune response analysis. Grants include funding from Stavanger University Hospital and a one-year scholarship from Helse Vest . Collaborations involve pathology departments at Stavanger University Hospital and the University of Oslo.













